Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.30
+5.00 (2.09%)
AAPL  263.33
+3.85 (1.48%)
AMD  246.91
+10.18 (4.30%)
BAC  53.55
+0.35 (0.66%)
GOOG  342.72
+4.19 (1.24%)
META  709.68
-6.82 (-0.95%)
MSFT  426.86
-3.43 (-0.80%)
NVDA  188.72
-2.41 (-1.26%)
ORCL  167.84
+3.26 (1.98%)
TSLA  421.29
-9.12 (-2.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.